Paper24672355
Emerging stent and balloon technologies in the femoropopliteal arteries.
Pastromas G and 4 others. ScientificWorldJournal, 2014. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Emerging stent and balloon technologies in the femoropopliteal arteries. Papers, record 24672355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24672355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Popliteal Artery | Major topic |
| Stents | Major topic |
| Biocompatible Materials | |
| Humans |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15129334 | Guidelines for stenting in infrainguinal arterial disease. | Cardiovasc Intervent Radiol | 2004 | https://conductscience.org/library/papers/15129334 | PubMed |
| 2 | 984302 | The fate of patients with intermittent claudication managed nonoperatively. | Am J Surg | 1976 | https://conductscience.org/library/papers/984302 | PubMed |
| 3 | 10666287 | Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). | J Vasc Surg | 2000 | https://conductscience.org/library/papers/10666287 | PubMed |
| 4 | 16363898 | Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. | J Endovasc Ther | 2005 | https://conductscience.org/library/papers/16363898 | PubMed |
| 5 | 11568332 | Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. | Radiology | 2001 | https://conductscience.org/library/papers/11568332 | PubMed |
| 6 | 18272892 | Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18272892 | PubMed |
| 7 | 10908211 | Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. | Circulation | 2000 | https://conductscience.org/library/papers/10908211 | PubMed |
| 8 | 18566179 | Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. | Radiology | 2008 | https://conductscience.org/library/papers/18566179 | PubMed |
| 9 | 23831445 | Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/23831445 | PubMed |
| 10 | 21953370 | Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. | Circ Cardiovasc Interv | 2011 | https://conductscience.org/library/papers/21953370 | PubMed |
| 11 | 23070104 | Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study. | Cardiovasc Intervent Radiol | 2013 | https://conductscience.org/library/papers/23070104 | PubMed |
| 12 | 11487673 | Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. | J Vasc Interv Radiol | 2001 | https://conductscience.org/library/papers/11487673 | PubMed |
| 13 | 17140820 | Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). | Eur J Vasc Endovasc Surg | 2007 | https://conductscience.org/library/papers/17140820 | PubMed |
| 14 | 20598480 | Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. | J Vasc Surg | 2010 | https://conductscience.org/library/papers/20598480 | PubMed |
| 15 | 12234956 | Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. | Circulation | 2002 | https://conductscience.org/library/papers/12234956 | PubMed |
| 16 | 23583245 | Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/23583245 | PubMed |
| 17 | 22545894 | Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. | J Endovasc Ther | 2012 | https://conductscience.org/library/papers/22545894 | PubMed |
| 18 | 21799474 | Role of total endoluminal superficial femoral artery bypass. | J Cardiovasc Surg (Torino) | 2011 | https://conductscience.org/library/papers/21799474 | PubMed |
| 19 | 22915325 | Peripheral applications of drug-coated balloons: past, present and future. | Cardiovasc Intervent Radiol | 2013 | https://conductscience.org/library/papers/22915325 | PubMed |
| 20 | 16672699 | Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16672699 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41078568 | Fractured Stents: The Silent Trigger of a Popliteal Artery Aneurysm. | Case Rep Vasc Med | 2025 | https://conductscience.org/library/papers/41078568 | PubMed |
| 39132346 | Atherectomy Plus Balloon Angioplasty for Femoropopliteal Disease Compared to Balloon Angioplasty Alone: A Systematic Review and Meta-analysis. | J Soc Cardiovasc Angiogr Interv | 2022 | https://conductscience.org/library/papers/39132346 | PubMed |
| 33768975 | Endovascular balloon angioplasty for infrainguinal arterial occlusive disease: Efficacy analysis. | Turk Gogus Kalp Damar Cerrahisi Derg | 2021 | https://conductscience.org/library/papers/33768975 | PubMed |
| 28526046 | BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial. | Trials | 2017 | https://conductscience.org/library/papers/28526046 | PubMed |
| 27921154 | Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries. | Cardiovasc Intervent Radiol | 2017 | https://conductscience.org/library/papers/27921154 | PubMed |
| 25435660 | Treating femoropopliteal disease: established and emerging technologies. | Semin Intervent Radiol | 2014 | https://conductscience.org/library/papers/25435660 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24672355
GET https://conductscience.org/api/papers/v1/24672355/references?page=2